MedPath

palleos healthcare GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Medidux™ Digital Health Application in Patients With HER2-positive Breast Cancer During Chemotherapy in Combination With HER2-targeted Therapy or Antibody-drug Conjugate Therapy.

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
Interventions
Device: medidux™ app
First Posted Date
2022-06-21
Last Posted Date
2025-03-10
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
585
Registration Number
NCT05425550
Locations
🇨🇭

Seespital Horgen-Onkologie, Horgen, Switzerland

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy

Phase 2
Completed
Conditions
Triple-negative Breast Cancer
Interventions
First Posted Date
2021-02-25
Last Posted Date
2024-11-04
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
416
Registration Number
NCT04770272
Locations
🇩🇪

Marienhospital Bottrop gGmbH; Klinik für Frauenheilkunde und Geburtshilfe;, Bottrop, Germany

Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy

Phase 4
Terminated
Conditions
Breast Neoplasm
Interventions
First Posted Date
2017-07-18
Last Posted Date
2022-01-06
Lead Sponsor
Palleos Healthcare GmbH
Target Recruit Count
532
Registration Number
NCT03220178
Locations
🇩🇪

University Hospital Mainz, Mainz, Germany

© Copyright 2025. All Rights Reserved by MedPath